Do GLP-1s Wreck Male Fertility? What I Actually Tell Men About Sperm Health
Nick came to see me last spring convinced he had ruined his chances of having a kid. He was 41, ran two restaurants on the Westside, and had spent eight months on semaglutide after his primary care doctor started him on it for an A1c of 6.2 and a BMI of 34. It worked — he’d lost 41 pounds, his blood pressure was normal for the first time since his early thirties, and his energy was back. Then he and his wife started trying to conceive, and someone in a Reddit thread told him GLP-1s destroy sperm. “I feel better than I have in ten years,” he said, “and now I’m being told I broke my fertility to get here.”
I’m Dr. Justin Houman, a board-certified urologist and fellowship-trained specialist in Male Reproductive Medicine and Surgery — a subspecialty completed at UCLA and held by fewer than 2% of urologists nationwide. I’m an Assistant Clinical Professor of Urology at Cedars-Sinai and practice at Tower Urology in Los Angeles, where I now field this exact question several times a week. Most of the public conversation about these medications has centered on women, but men deserve a real answer too.
So I ran his labs. His sperm count and motility came back meaningfully better than an analysis he’d done at a fertility clinic two years earlier, before the medication, and his total testosterone had climbed from 288 to 512 without ever touching testosterone therapy. Nick didn’t break anything — he’d spent eight months treating the actual problem.
The Short Version
GLP-1 medications may be associated with better sperm parameters and higher testosterone, primarily in men with obesity or metabolic dysfunction, and most of that benefit appears to come from weight loss rather than a direct effect on sperm. They aren’t recommended while actively trying to conceive, so timing and provider guidance matter — the fuller picture is below.
Why the Fertility Question Is a Fair One
GLP-1 receptor agonists — semaglutide (Ozempic, Wegovy), liraglutide, and tirzepatide — were developed for type 2 diabetes and later adopted for weight management.
The connection to fertility isn’t a stretch. Excess weight, insulin resistance, and chronic inflammation are all tied to lower sperm quality and reduced testosterone, and I see it weekly in my Los Angeles clinic: a man with a BMI in the mid-thirties, a testosterone in the 200s, and a poor semen analysis, where the metabolic picture is doing most of the damage. So when a medication targets those factors, it’s fair to ask whether better metabolic health supports sperm health too. So far the answer appears to be yes — with qualifications.
What the Research Actually Shows
For men with metabolic concerns, the early evidence is cautiously encouraging. A 2026 systematic review of 10 studies covering 639 men found GLP-1 use consistently associated with higher total testosterone, particularly in men with obesity, type 2 diabetes, or functional hypogonadism, and some also reported improved semen quality. The authors suggested GLP-1s may be fertility-sparing alternatives to testosterone therapy in select cases, while stressing that larger controlled studies are still needed.
Two things deserve perspective: nearly all of the benefit occurred in men who started with metabolic dysfunction — Nick’s exact profile — and the picture isn’t uniformly positive, with some reviews stressing how much remains unproven in humans. My read: GLP-1s may help sperm health, but mainly in men who already have weight or metabolic issues. I wouldn’t prescribe one for fertility alone, but if you have metabolic dysfunction and a good reason to be on one anyway, the evidence is reassuring rather than concerning.
Why It Might Work
A few overlapping mechanisms explain why the effect concentrates in men with metabolic problems:
- Weight Loss Itself: Losing excess weight is associated with improved sperm concentration, count, and motility, and is almost certainly the primary driver of any benefit.
- Better Insulin Sensitivity: Reduced inflammation and improved metabolic control create a healthier environment for sperm production, since testicular tissue is metabolically demanding and sensitive to oxidative stress.
- Possible Direct Effects: GLP-1 receptors have been found on Leydig cells, Sertoli cells, and sperm themselves, and some lab studies suggest GLP-1 signaling may support sperm metabolism and motility — though this work is early and mostly preclinical.
My estimate: roughly 70 to 80% of the benefit is weight loss and metabolic improvement, not the drug acting on the testis directly. What helps sperm health here is largely what helps whole-body health — as it always has been.
Timing and the “Trying to Conceive” Question
This is where Nick’s situation got specific, because he and his wife weren’t planning to conceive someday — they were trying now. GLP-1s are generally not recommended during pregnancy or while actively trying, and most specialists advise stopping them well before conception, largely for maternal and fetal safety. Any decision to start, continue, or stop one for fertility reasons belongs with your provider, not a search bar.
It’s also worth separating GLP-1s from testosterone therapy, which men conflate constantly. Testosterone replacement suppresses the body’s own sperm production — I’ve seen men arrive with azoospermia after a year on a protocol from a clinic that never asked about family planning. GLP-1s are interesting precisely because they appear to raise testosterone without that suppression, though that still doesn’t make them a fertility treatment.
Who I Would, and Wouldn’t, Consider This For
Not every man is a candidate. I’d steer clear of a GLP-1 for sperm health when:
- The Metabolic Profile Is Normal: Labs are already healthy, with no obesity or insulin resistance.
- He’s Actively Trying Now: Discontinuation should happen well before active trying.
- Foundations Are Untested: He hasn’t genuinely tried diet, exercise, and supplementation first, since those cost far less and work.
I’d consider it, alongside a patient’s primary care provider, in narrower cases:
- A Two-for-One Intervention: A man with obesity or metabolic dysfunction who also wants to improve sperm health.
- A Clear Conception Timeline: A man with type 2 diabetes or prediabetes on a path to conception in three to six months.
- Persistent Dysfunction: A man who has taken lifestyle changes seriously and still has metabolic dysfunction with poor semen parameters.
Nick fell squarely in the second group. Most men who ask me about this do not.
What You Can Do Starting Today
Whether or not a GLP-1 enters your picture, the foundations of sperm health are available now. Sperm develop over roughly two to three months, so the habits you build this week show up in a semen analysis this fall:
- Blood-Sugar-Friendly Plates: Build meals around quality protein, colorful produce, healthy fats, and fiber-rich carbs.
- Regular Movement: Move most days and include strength training.
- Protected Sleep: Guard seven to nine hours — the change most of my patients resist and most of them need.
- Fewer Toxins: Limit alcohol, smoking, and nicotine, and reduce exposure to endocrine-disrupting chemicals where you reasonably can.
- Smart Supplementation: Fill gaps with a well-formulated male prenatal containing zinc, selenium, methylated B vitamins, antioxidants, and omega-3s.
None of it is glamorous. All of it works, whether or not you ever fill a prescription.
Where Nick Landed
He and his wife decided, with his primary care doctor and with me, to continue the semaglutide another three months, then taper off ahead of active trying — holding those gains through nutrition, training, and sleep rather than the drug. A GLP-1 is not a fertility drug; for the right man, it’s a metabolic intervention whose effects happen to reach the testis. If you’re that man, the evidence should reassure you; if not, the foundations still matter more than anything from a pen.
Talk With Dr. Houman About Your Fertility
If you have questions about your fertility, your testosterone, or whether a medication you’re taking is helping or hurting your reproductive health, that’s a conversation worth having with someone who does this every day. I care for men throughout Los Angeles, including Beverly Hills, Santa Monica, and West Hollywood, with individualized evaluations built around your whole health.
To schedule with Dr. Justin Houman, contact Tower Urology at 8635 W 3rd St, Suite 1W, Los Angeles, CA 90048, or call (310) 854-9898.
Frequently Asked Questions
-
Early research suggests semaglutide and other GLP-1s may improve sperm count and concentration in men with obesity or metabolic dysfunction, largely through weight loss; the evidence is still limited, and effects in men without metabolic concerns are unclear.
-
Several studies associate GLP-1 use with higher total testosterone, especially in men with obesity, type 2 diabetes, or functional hypogonadism, and unlike testosterone therapy, they don't appear to suppress the body's own sperm production — though more research is needed.
-
They aren't established as a fertility treatment and aren't recommended while actively trying to conceive, so any decision should be made with your provider based on your health, goals, and timeline.
-
GLP-1 receptors have been found in male reproductive tissue and some lab studies suggest direct effects, but for now most of the observed benefit appears tied to weight loss and metabolic improvement.
Posted on behalf of
8635 W 3rd St Suite 1W
Los Angeles, CA 90048
Phone: (310) 854-9898
[email protected]
Monday - Friday 8:30 am – 5:00 pm
